Pharmacological aspects of application of 1,2,4-triazole-3-thiol furan derivatives
DOI:
https://doi.org/10.14739/2409-2932.2016.3.78004Keywords:
1, 2, 4-triazole-3-thiols, Furan «Remains», Molecules Modification, Pharmacological ActivityAbstract
Introduction. Nowadays 1,2,4-triazole-3-thiol furan derivatives have established themselves as a separate class of promising bioactive compounds. Presented substance is practically non-toxic and exhibits various kinds of pharmacological activity. New original drug «Tryfuzol» in two dosage forms (1% injectable solution and 1% solution for oral administration) triumphantly entered the practice of the national veterinary. The most attractive in pharmacological aspects are water-soluble compounds 5-(furan-2-yl)-4R-1,2,4-triazole-3-thiols. Other classes of 1,2,4-triazole-3-thiol furan derivatives are also in considerable scientific interest. However, despite the presence of a sufficiently large number of publications, the issue of pharmacological tests systematization of the 1,2,4-triazole-3-thiol furan derivatives is still open.
In this way the aim of our work was the systematization of the available sources of domestic authors.
Materials and methods. Our work presents the results of systematic analysis of the available domestic literature related to the study of pharmacological properties of 1,2,4-triazole-3-thiol furan derivatives.
Research results. It is known that 1,2,4-triazole-3-thiol furan derivatives have wide range of properties and biological activities. Thioacetate salts of corresponding acids show the highest results. The authors investigated the properties of water-soluble compounds of 1,2,4-triazole-3-thiol furan derivatives. Another group of compounds was investigated on hypoglycemic activity. It was established that the most active were piperidine 2-(5-(furan-2-yl)-4-(3-methylphenyl)-1,2,4-triazol-3-ylthio) acetate and piperidine 2-(5-(furan-2-yl)-4-phenyl-1,2,4-triazol-3-ylthio) acetate.
Conclusion. The scientific potential of the domestic pharmaceutical industry has no doubts for today. The literature analysis of Russian authors proves the obvious prospect of further research of biologically active compounds among 1,2,4-triazole-3-thiol furan derivatives.
References
Parchenko, V. V. (2006) Syntez, fizyko-khimichni ta biolohichni vlastyvosti pokhidnykh 1,2,4-triazol-3-tionu, yaki mistiat yadro furanu (Dis… kand. farm. nauk). [Synthesis, physico-chemical and biological properties of the 1,2,4-triazole-3-thione derivatives which contain furan core. Dr. farm. sci. diss.]. Kyiv. [in Ukrainian].
Parchenko, V. V. (2014) Syntez, peretvorennia, fizyko-khimichni ta biolohichni vlastyvosti v riadi 5-furylzamishchenykh 1,2,4-triazol-3-tioniv (Dis… dokt. farm. nauk). [Synthesis, physico-chemical and biological properties of the 1,2,4-triazole-3-thione 5-furilderivatives. Dr. farm. sci. diss.]. Zaporizhzhia. [in Ukrainian].
Parchenko, V. V., Panasenko, O. I., & Knysh, Ye. H. (2007) Fizyko-khimichni vlastyvosti ta hostra toksychnist pokhidnykh 3-atsylalkiltio-1,2,4-triazoliv [Physical-chemical properties and cute toxicity of 3-acylalkylthio-1,2,4-triazole derivatives]. Farmatsevtychyi chasopys, 2(2), 49–53. [in Ukrainian].
Parchenko, V. V., Panasenko, O. I., Knysh, Ye. H., & Zoria, B. P. (2007) Vyvchennia vplyvu na funktsiiu nyrok S-pokhidnykh 5-(furan-2-il)-4-R1-1,2,4-triazol-3-tioniv [Studying of the 5-(furan-2-yl)-4-R1-1,2,4-triazole-3-thions S-derivatives influence on kidney functions]. Zaporozkskij medicinskij zhurnal, 6, 117–119. [in Ukrainian].
Parchenko, V. V., Knysh, Ye. H., Panasenko, O. I., Samura, I. B., Litovchenko, A. L., & Samura, B. A. (2007) [Synthesis, physico-chemical properties and anticonvulsant activity of 2-[5-(furan-2-yl)-4R1-1,2,4-triazole-3-yltio]-1-aryletanones]. Aktualni pytannia farmatsevtychnoi ta medychnoi nauky ta praktyky, 20, 150–154. [in Ukrainian].
Parchenko, V. V. (2011) Protyvirusna aktyvnist´ pokhidnykh 1,2,4-triazolu [Antiviral activity of 1,2,4-triazole derivatives]. Farmatsevtychnyi zhurnal, 3, 49–53. [in Ukrainian].
Parchenko, V. V., Panasenko, O. I., Knysh, Ye. H., Dzublyk, I. V., Trohymenko, O. P., & Panaseko, T. V. (2008) Protyvirusna aktyvnist solei 2-[5-(furan-2-il)-4-R-1,2,4-tryazol-3-iltio]atsetatnykh kyslot [Antiviral activity of 2-[5-(furan-2-yl)-4-R-1,2,4-triazole-3-iltio] acetic acid salts]. Farmatsevtychnyi zhurnal, 6, 79–85. [in Ukrainian].
Parchenko, V. V., Panasenko, O. I., Knysh, E. H., Izdepskyi V. Yu., Ilina, O. V., & Pogorluk, A. Yu. (2009) Piperydynii 2-[5-(furan-2-il)-4-fenil-1,2,4-triazol-3-iltio]atsetat, shcho vyiavliaie protyvirusnu aktyvnist po vidnoshenniu do virusiv kuriachykh embrioniv [Piperediniy 2-[5-(furan-2-yl-4-fenil-1,2,4-triazole-3-yltio]acetate which shows antiviral activity against chicken embryos viruses]. Zaporozkskij medicinskij zhurnal, 1, 97–98. [in Ukrainian].
Parchenko, V. V., Panasenko, O. I., Knysh, E. H., Svintozelskyi, O. O., & Samura, B. A. (2009) Protyzapalna aktyvnist S-pokhidnykh 5-(furan-2-il)-4-R-1,2,4-triazol-3-tioniv [Inflammatory activity of 5-(furan-2-yl)-4-R-1,2,4-triazole-3-thione S-derivatives]. Zaporozkskij medicinskij zhurnal, 11(4), 100–102. [in Ukrainian].
Knysh, E. H., Panasenko, O. I., Parchenko, V. V., Kaplaushenko, A. H., Hotsulia, A. S., Kulish, S. M., & Kaplaushenko, T. M. (patentee) (2008) Pat. 32765 Ukraina, C07D 249/00 A61K 31/4196. Soli 1,2,4-tryazol-3-iltio-atsetatnoi kysloty, shcho vyiavliaiut antyhipoksychnu ta protynabriakovu aktyvnist shchodo nabriaku mozku, obumovlenoho shyrokosmuhovoiu vibratsiieiu [Pat. 32765 Ukraine C07D 249/00, A61K 31/4196. Salts of 1,2,4-triazole-3-iltio acetic acid that exhibit antihypoxical activity on cerebral edema caused by broadband vibration]. Biuleten, 10. [in Ukrainian].
Pruhlo, Ye. S., Bіlai, І. M., Kaplaushenko, A. H., & Parchenko, V. V. (2011) Vyvchennia hipohlikemichnoi aktyvnosti pokhidnykh 1,2,4-triazolu pry eksperymentalnii hiperlipidemii [The hypoglycemic activity study of the 1,2,4-triazole derivatives in experimental hyperlipidemia]. Farmatsevtychnyi zhurnal, 1, 74–78. [in Ukrainian].
Bilai, I. M., Halushko, A. Yu., Hnitko, I. V., Pruhlo, Ye. S., Kaplaushenko, A. H., Parchenko, V. V., et al. (2013) Hipolipidemichna aktyvnist deiakykh pokhidnykh 1,2,4-triazolu [The hypolipidemic activity of some 1,2,4-triazole derivatives]. Aktualni pytannya farmatsevtychnoi i medychnoi nauky ta praktyky, 1(11), 15–17. . [in Ukrainian].
Pruglo, Ye. S., Bіlai, І. M., Parchenko, V. V., & Kaplaushenko, A. H. (2009) Hipo-β-lipoproteidemichni vlastyvosti novykh zamishchenykh 1,2,4-triazolu [Hypo-β-lipoproteidemic properties of new 1,2,4-triazole substitutes]. Ukrainskyi naukovo-medychnyi molodizhnyi zhurnal, 3, 19–21. . [in Ukrainian].
Pruglo, Ye. S., Bіlai, І. M., Kaplaushenko, A. H., Parchenko, V. V., Hotsulia, A. S., & Hotsulia T. S. (2010) Antyoksydantna aktyvnist deiakykh pokhidnykh 1,2,4-traizolu pry eksperymentalnii hiperlipidemii [The antioxidant activity of some derivatives of the 1,2,4-traіzol at the experimental hyperlipidemia]. Farmatsevtychnyi chasopys, 1(10), 61–65. [in Ukrainian].
Parchenko, V. V., Panasenko, O. I., Knysh, Ye. H., Svintozelskyi, O. O., Samura, B. A. (2009) Neirotropna aktyvnist S-pokhidnykh 5-(furan-2-il)-4-R-1,2,4-triazol-3-tioniv [Neurotropic activity of 5-(furan-2-yl)-4-R-1,2,4-triazole-3-thione S-derivatives] Farmatsevtychnyi chasopys, 3(9), 34–37. [in Ukrainian].
Sherbyna, R. O., Parchenko, V. V., Pavlov, S. V., Panasenko, O. I., Knysh, Ye. H., & Belenichev, I. F. (2011) Neiroprotektyvna aktyvnist S-pokhidnykh 1,2,4-triazolu [Neuroprotective activity of the 1,2,4-triazole S-derivatives]. Zaporozhskyi medytsynskyi zhurnal, 13(1), 94–97. [in Ukrainian].
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
